pifithrin has been researched along with Craniofacial Abnormalities in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ueharu, H | 1 |
| Pan, H | 1 |
| Hayano, S | 1 |
| Zapien-Guerra, K | 1 |
| Yang, J | 1 |
| Mishina, Y | 1 |
1 other study available for pifithrin and Craniofacial Abnormalities
| Article | Year |
|---|---|
Augmentation of bone morphogenetic protein signaling in cranial neural crest cells in mice deforms skull base due to premature fusion of intersphenoidal synchondrosis.
Topics: Animals; Animals, Newborn; Apoptosis; Bone Morphogenetic Proteins; Cell Proliferation; Chondrocytes; | 2023 |